Portal:COVID-19/FeaturedPathways
From WikiPathways
(→SARS-CoV-2 Pathways) |
(removed deleted pathway WP5017) |
||
Line 26: | Line 26: | ||
|width=100px|{{#pwImage:Pathway:WP5038|250px||SARS-CoV-2 mitochondrial interactions}} | |width=100px|{{#pwImage:Pathway:WP5038|250px||SARS-CoV-2 mitochondrial interactions}} | ||
|width=100px|{{#pwImage:Pathway:WP5039|250px||SARS-CoV-2 Innate Immunity Evasion and Cell-specific immune response}} | |width=100px|{{#pwImage:Pathway:WP5039|250px||SARS-CoV-2 Innate Immunity Evasion and Cell-specific immune response}} | ||
- | |||
- | |||
|width=100px|{{#pwImage:Pathway:WP5063|250px||FOXP3 in COVID-19 (Homo sapiens)}} | |width=100px|{{#pwImage:Pathway:WP5063|250px||FOXP3 in COVID-19 (Homo sapiens)}} | ||
+ | |- | ||
+ | |||
|width=100px|{{#pwImage:Pathway:WP5065|250px||SARS-CoV-2 altering angiogenesis via NRP1 (Homo sapiens)}} | |width=100px|{{#pwImage:Pathway:WP5065|250px||SARS-CoV-2 altering angiogenesis via NRP1 (Homo sapiens)}} | ||
|width=100px|{{#pwImage:Pathway:WP5076|250px||Soluble ACE2-mediated cell entry of SARS-CoV-2 (Homo sapiens)}} | |width=100px|{{#pwImage:Pathway:WP5076|250px||Soluble ACE2-mediated cell entry of SARS-CoV-2 (Homo sapiens)}} | ||
Line 99: | Line 99: | ||
* [[Pathway:WP5038]] | * [[Pathway:WP5038]] | ||
* [[Pathway:WP5039]] | * [[Pathway:WP5039]] | ||
- |
Revision as of 16:27, 8 June 2021
Contents |
SARS-CoV-2 Pathways
Image does not exist Collaborative project for curation of biological processes involved in the COVID-19 disease after SARS-Cov-2 infection. |
Image does not exist SARS-CoV-2 includes a novel Orf10 that interacts with multiple members of the Cullin 2 ubiquitin ligase complex. |
Image does not exist The induction and signaling of type I interferon with specific SARS-CoV-2 protein and relevant drug. |
Image does not exist |
Image does not exist Orf3a from SARS-CoV has been shown to bind TRAF3 and activate the NLRP3 inflammasome. |
Image does not exist |
Image does not exist Experimental pathway to investigate overlap of virus-host interaction and adverse outcome pathways |
Image does not exist Virus-host interactome and proteomic survey of PMBCs from COVID-19 patients reveal potential virulence factors influencing SARS-CoV-2 pathogenesis |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Other coronaviruses: MERS, SARS-CoV, etc
Image does not exist Lipid metabolism alternations that are related to infection by the corona virus. |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
More about ACE2
Image does not exist |
Image does not exist |
Pathways from Reactome
Image does not exist |
Image does not exist |
List of featured pathways:
- Pathway:WP4846
- Pathway:WP4860
- Pathway:WP4868
- Pathway:WP4927
- Pathway:WP4876
- Pathway:WP4883
- Pathway:WP4891
- Pathway:WP4884
- Pathway:WP4904
- Pathway:WP4936